<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36992274</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>17</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Patients' Post-/Long-COVID Symptoms, Vaccination and Functional Status-Findings from a State-Wide Online Screening Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">691</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines11030691</ELocationID><Abstract><AbstractText>(1) Background: Better understanding of post-/long-COVID and limitations in daily life due to the symptoms as well as the preventive potential of vaccinations is required. It is unclear whether the number of doses and timepoint interrelate with the trajectory of post-/long-COVID. Accordingly, we examined how many patients positively screened with post-/long-COVID were vaccinated and whether the vaccination status and the timepoint of vaccination in relation to the acute infection were related to post-/long-COVID symptom severity and patients' functional status (i.e., perceived symptom severity, social participation, workability, and life satisfaction) over time. (2) Methods: 235 patients suffering from post-/long-COVID were recruited into an online survey in Bavaria, Germany, and assessed at baseline (T1), after approximately three weeks (T2), and approximately four weeks (T3). (3) Results: 3.5% were not vaccinated, 2.3% were vaccinated once, 20% twice, and 53.3% three times. Overall, 20.9% did not indicate their vaccination status. The timepoint of vaccination was related to symptom severity at T1, and symptoms decreased significantly over time. Being vaccinated more often was associated with lower life satisfaction and workability at T2. (4) Conclusions: This study provides evidence to get vaccinated against SARS-CoV-2, as it has shown that symptom severity was lower in those patients who were vaccinated prior to the infection compared to those getting infected prior to or at the same time of the vaccination. However, the finding that being vaccinated against SARS-CoV-2 more often correlated with lower life satisfaction and workability requires more attention. There is still an urgent necessity for appropriate treatment for overcoming long-/post-COVID symptoms efficiently. Vaccination can be part of prevention measures, and there is still a need for a communication strategy providing objective information about the usefulness and risks of vaccinations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lippke</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8272-0399</Identifier><AffiliationInfo><Affiliation>School of Business, Social &amp; Decision Sciences, Constructor University Bremen, 28759 Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinn</LastName><ForeName>Robin</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2640-8325</Identifier><AffiliationInfo><Affiliation>School of Business, Social &amp; Decision Sciences, Constructor University Bremen, 28759 Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Derksen</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4663-1882</Identifier><AffiliationInfo><Affiliation>School of Business, Social &amp; Decision Sciences, Constructor University Bremen, 28759 Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahmen</LastName><ForeName>Alina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8591-874X</Identifier><AffiliationInfo><Affiliation>School of Business, Social &amp; Decision Sciences, Constructor University Bremen, 28759 Bremen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Klinikum Wolfsburg, 38440 Wolfsburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>202120222023</GrantID><Agency>Constructor University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">age</Keyword><Keyword MajorTopicYN="N">breakthrough infections</Keyword><Keyword MajorTopicYN="N">life satisfaction</Keyword><Keyword MajorTopicYN="N">number of doses</Keyword><Keyword MajorTopicYN="N">perceived symptom severity</Keyword><Keyword MajorTopicYN="N">sex</Keyword><Keyword MajorTopicYN="N">social participation</Keyword><Keyword MajorTopicYN="N">timepoint</Keyword><Keyword MajorTopicYN="N">workability</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36992274</ArticleId><ArticleId IdType="pmc">PMC10051253</ArticleId><ArticleId IdType="doi">10.3390/vaccines11030691</ArticleId><ArticleId IdType="pii">vaccines11030691</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rabady S., Altenberger J., Brose M., Denk-Linnert D.-M., Fertl E., G&#xf6;tzinger F., de La Cruz Gomez Pellin M., Hofbaur B., Hoffmann K., Hoffmann-Dorninger R., et al. Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien [Guideline S1: Long COVID: Differential diagnosis and treatment strategies] Wien. Klin. Wochenschr. 2021;133:237&#x2013;278. doi: 10.1007/s00508-021-01974-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-021-01974-0</ArticleId><ArticleId IdType="pmc">PMC8633909</ArticleId><ArticleId IdType="pubmed">34851455</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Coronavirus Disease (COVID-19): Post COVID-19 Condition.  [(accessed on 14 January 2023)].  Available online:  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition?gclid=CjwKCAiAk--dBhABEiwAchIwkRmIcHA8DGVkY2JGhWBe5W0ZpbehqxVYZ_QUbaaNO-a9pneEpi42axoCkhcQAvD_BwE.</Citation></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T., Yan M.Z., Li X., Lau E.H.Y. Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: A systematic review and meta-analysis. Infection. 2022;50:1067&#x2013;1109. doi: 10.1007/s15010-022-01862-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01862-3</ArticleId><ArticleId IdType="pmc">PMC9244338</ArticleId><ArticleId IdType="pubmed">35750943</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., Shaar B.A., Almamlouk R., Riaz M., Obeidat M., Obeidat Y., Gerberi D., Taha R.M., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Parkin A., Makower S., Greenwood D.C. Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross-sectional evaluation from a community COVID rehabilitation service. J. Med. Virol. 2022;94:1419&#x2013;1427. doi: 10.1002/jmv.27456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27456</ArticleId><ArticleId IdType="pmc">PMC8661751</ArticleId><ArticleId IdType="pubmed">34783052</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum P., Do L., Deterding L., Lier J., Kunis I., Saur D., Classen J., Wirtz H., Laufs U. Cardiac function in relation to functional status and fatigue in patients with post-COVID syndrome. Sci. Rep. 2022;12:19575. doi: 10.1038/s41598-022-24038-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24038-3</ArticleId><ArticleId IdType="pmc">PMC9664421</ArticleId><ArticleId IdType="pubmed">36380000</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E.A., O&#x2019;Connor R.C., Perry V.H., Tracey I., Wessely S., Arseneault L., Ballard C., Christensen H., Cohen Silver R., Everall I., et al. Multidisciplinary research priorities for the COVID-19 pandemic: A call for action for mental health science. Lancet Psychiatry. 2020;7:547&#x2013;560. doi: 10.1016/S2215-0366(20)30168-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30168-1</ArticleId><ArticleId IdType="pmc">PMC7159850</ArticleId><ArticleId IdType="pubmed">32304649</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel A.N., Zhu S., Cooper N., Roderick P., Alwan N., Tarrant C., Ziauddeen N., Yao G.L. Impact of COVID-19 on health-related quality of life of patients: A structured review. PLoS ONE. 2021;16:e0259164. doi: 10.1371/journal.pone.0259164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259164</ArticleId><ArticleId IdType="pmc">PMC8553121</ArticleId><ArticleId IdType="pubmed">34710173</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerer L., Cherney L., Roth E. Characterizing symptoms and impact of &#x201c;Long COVID&#x201d;: A qualitative perspective. Arch. Phys. Med. Rehabil. 2022;103:e49. doi: 10.1016/j.apmr.2022.08.553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2022.08.553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocsovszky Z., Otohal J., Ber&#xe9;nyi B., Juh&#xe1;sz V., Skoda R., Bokor L., Dohy Z., Szab&#xf3; L., Nagy G., Becker D., et al. The associations of long-COVID symptoms, clinical characteristics and affective psychological constructs in a non-hospitalized cohort. Physiol. Int. 2022;109:230&#x2013;245. doi: 10.1556/2060.2022.00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/2060.2022.00030</ArticleId><ArticleId IdType="pubmed">35575989</ArticleId></ArticleIdList></Reference><Reference><Citation>Deselaers C., Dahmen A., Lippke S. Impact of the COVID-19 pandemic on CSR activities of healthcare providers. Int. J. Environ. Res. Public Health. 2022;20:368. doi: 10.3390/ijerph20010368.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20010368</ArticleId><ArticleId IdType="pmc">PMC9819171</ArticleId><ArticleId IdType="pubmed">36612690</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., Villa G., de Lorenzo R., Rovere Querini P., Benedetti F. Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue. J. Psychiatr. Res. 2022;155:112&#x2013;119. doi: 10.1016/j.jpsychires.2022.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.08.008</ArticleId><ArticleId IdType="pmc">PMC9391361</ArticleId><ArticleId IdType="pubmed">36029623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis R.H., Santillana M., Ognyanova K., Safarpour A., Lunz Trujillo K., Simonson M.D., Green J., Quintana A., Druckman J., Baum M.A., et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw. Open. 2022;5:e2238804. doi: 10.1001/jamanetworkopen.2022.38804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Righi E., Mirandola M., Mazzaferri F., Dossi G., Razzaboni E., Zaffagnini A., Ivaldi F., Visentin A., Lambertenghi L., Arena C., et al. Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study. J. Infect. 2022;84:566&#x2013;572. doi: 10.1016/j.jinf.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8828388</ArticleId><ArticleId IdType="pubmed">35150765</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.-T., Perrodeau E., Saldanha J., Pane I., Ravaud P. Efficacy of COVID-19 vaccination on the symptoms of patients with long COVID: A target trial emulation using data from the comPaRe e-cohort in France. SSRN Electron. J. 2021;12:2057. doi: 10.2139/ssrn.3932953.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3932953</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofarides A.G., Christaki E., Milionis H., Nikolopoulos G.K. Effect of vaccination against SARS-CoV-2 on long COVID-19: A narrative review. Life. 2022;12:2057. doi: 10.3390/life12122057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12122057</ArticleId><ArticleId IdType="pmc">PMC9785763</ArticleId><ArticleId IdType="pubmed">36556422</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnivesky J.P., Govindarajulu U., Bagiella E., Goswami R., Kale M., Campbell K.N., Meliambro K., Chen Z., Aberg J.A., Lin J.J. Association of vaccination with the persistence of post-COVID symptoms. J. Gen. Intern. Med. 2022;37:1748&#x2013;1753. doi: 10.1007/s11606-022-07465-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07465-w</ArticleId><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul E., Fancourt D. Health behaviours the month prior to COVID-19 infection and the development of self-reported long COVID and specific long COVID symptoms: A longitudinal analysis of 1581 UK adults. BMC Public Health. 2022;22:1716. doi: 10.1186/s12889-022-14123-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-14123-7</ArticleId><ArticleId IdType="pmc">PMC9462889</ArticleId><ArticleId IdType="pubmed">36085055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernsting A., Schwarzer R., Lippke S., Schneider M. &#x2018;I do not need a flu shot because I lead a healthy lifestyle&#x2019;: Compensatory health beliefs make vaccination less likely. J. Health Psychol. 2013;18:825&#x2013;836. doi: 10.1177/1359105312455076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105312455076</ArticleId><ArticleId IdType="pubmed">22956679</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Golenbock D., Latz E., Morgan D., Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer&#x2019;s Res. Ther. 2020;12:69. doi: 10.1186/s13195-020-00640-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T., Hirose M., Inoue Y., Kunishima H., Otsubo T., Matsuda T. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID. J. Med. Virol. 2022;94:3416&#x2013;3420. doi: 10.1002/jmv.27689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27689</ArticleId><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Pijnenburg L., Chatelus E., Arnaud L., Gottenberg J.-E., Sibilia J., Felten R. Effect of SARS-CoV-2 vaccination on symptoms from post-acute sequelae of COVID-19: Results from the nationwide VAXILONG study. Vaccines. 2021;10:46. doi: 10.3390/vaccines10010046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010046</ArticleId><ArticleId IdType="pmc">PMC8781023</ArticleId><ArticleId IdType="pubmed">35062706</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Al-Rubaye H.T., Almulla A.F., Al-Hadrawi D.S., Stoyanova K., Kubera M., Al-Hakeim H.K. Lowered quality of life in long COVID is predicted by affective symptoms, chronic fatigue syndrome, inflammation and neuroimmunotoxic pathways. Int. J. Environ. Res. Public Health. 2022;19:10362. doi: 10.3390/ijerph191610362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191610362</ArticleId><ArticleId IdType="pmc">PMC9408685</ArticleId><ArticleId IdType="pubmed">36011997</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L., Tosto-Mancuso J., Wood J., Cortes M., Kontorovich A., McCarthy D., Rizk D., Rozanski G., Breyman E., Nasr L., et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am. J. Phys. Med. Rehabil. 2022;101:48&#x2013;52. doi: 10.1097/PHM.0000000000001910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P., Gorelik Y., Zayyad H., Wertheim O., Wiegler K.B., Abu Jabal K., Dror A.A., Nazzal S., Glikman D., Edelstein M. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: Cross-sectional study 2020-21, Israel. NPJ Vaccines. 2022;7:101. doi: 10.1038/s41541-022-00526-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-022-00526-5</ArticleId><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Trajectory of long COVID symptoms after COVID-19 vaccination: Community based cohort study. BMJ Clin. Res. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain W.D., Sherwood O., Banerjee A., van der Togt V., Hishmeh L., Rossman J. The impact of COVID vaccination on symptoms of long COVID: An international survey of people with lived experience of Long COVID. Vaccines. 2022;10:652. doi: 10.3390/vaccines10050652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050652</ArticleId><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Hanitsch L.G., Zoller T., Steinbeis F., Haffke M., Rudolf G., Heidecker B., et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahmen A., Keller F.M., Derksen C., Rinn R., Becker P., Lippke S. Screening and assessment for post-acute COVID-19 syndrome (PACS), guidance by personal pilots and support with individual digital trainings within intersectoral care: A study protocol of a randomized controlled trial. BMC Infect. Dis. 2022;22:693. doi: 10.1186/s12879-022-07584-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07584-z</ArticleId><ArticleId IdType="pmc">PMC9377288</ArticleId><ArticleId IdType="pubmed">35971066</ArticleId></ArticleIdList></Reference><Reference><Citation>Beierlein C., Kovaleva A., L&#xe1;szl&#xf3; Z., Kemper C.J., Rammstedt B. Kurzskala zur Erfassung der Allgemeinen Lebenszufriedenheit (L-1) GESIS&#x2014;Leibniz-Institut f&#xfc;r Sozialwissenschaften; K&#xf6;ln, Germany: 2015.</Citation></Reference><Reference><Citation>Mergenthal K., G&#xfc;thlin C. Einflussgr&#xf6;&#xdf;en auf die Arbeitszufriedenheit von Medizinischen Fachangestellten. Z. Evid. Fortbild. Qual. Gesundhwes. 2021;167:78&#x2013;85. doi: 10.1016/j.zefq.2021.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.zefq.2021.09.006</ArticleId><ArticleId IdType="pubmed">34815195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemh&#xf6;fer C., Gutenbrunner C., Schiller J., Loudovici-Krug D., Best N., B&#xf6;kel A., Sturm C. Assessment of rehabilitation needs in patients after COVID-19: Development of the COVID-19-rehabilitation needs survey. J. Rehabil. Med. 2021;53:jrm00183. doi: 10.2340/16501977-2818.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2818</ArticleId><ArticleId IdType="pmc">PMC8814869</ArticleId><ArticleId IdType="pubmed">33764478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilmarinen J. The Work Ability Index (WAI) Occup. Med. 2006;57:160. doi: 10.1093/occmed/kqm008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqm008</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagodics B., Szab&#xf3; &#xc9;. Is intergroup discrimination triggered by vaccination status? Exploring some social aspects of vaccinations during the COVID-19 pandemic. J. Soc. Psychol. 2022;8:1&#x2013;15. doi: 10.1080/00224545.2022.2085074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00224545.2022.2085074</ArticleId><ArticleId IdType="pubmed">35674409</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert Koch Institut  Digitales Impfquotenmonitoring zur COVID-19-Impfung.  [(accessed on 16 March 2023)].  Available online:  https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Daten/Impfquoten-Tab.html.</Citation></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., Canas L.S., Graham M.S., Klaser K., Modat M., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Harrison P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Ailshire J.A., Crimmins E.M. Long COVID and symptom trajectory in a representative sample of Americans in the first year of the pandemic. Sci. Rep. 2022;12:11647. doi: 10.1038/s41598-022-15727-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15727-0</ArticleId><ArticleId IdType="pmc">PMC9264749</ArticleId><ArticleId IdType="pubmed">35804058</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D., Steptoe A., Bu F. Psychological consequences of long COVID: Comparing trajectories of depressive and anxiety symptoms before and after contracting SARS-CoV-2 between matched long- and short-COVID groups. Br. J. Psychiatry J. Ment. Sci. 2022;222:1&#x2013;8. doi: 10.1192/bjp.2022.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2022.155</ArticleId><ArticleId IdType="pmc">PMC7614126</ArticleId><ArticleId IdType="pubmed">36458509</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Cancela-Cilleruelo I., Moro-L&#xf3;pez-Menchero P., Rodr&#xed;guez-Jim&#xe9;nez J., Pellicer-Valero O.J. Exploring the trajectory recovery curve of the number of post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study. Int. J. Infect. Dis. 2022;117:201&#x2013;203. doi: 10.1016/j.ijid.2022.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.02.010</ArticleId><ArticleId IdType="pmc">PMC8826603</ArticleId><ArticleId IdType="pubmed">35150911</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Cancela-Cilleruelo I., Moro-L&#xf3;pez-Menchero P., Rodr&#xed;guez-Jim&#xe9;nez J., Pellicer-Valero O.J. Trajectory curves of post-COVID anxiety/depressive symptoms and sleep quality in previously hospitalized COVID-19 survivors: The LONG-COVID-EXP-CM multicenter study. Psychol. Med. 2022:201&#x2013;203. doi: 10.1017/S003329172200006X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S003329172200006X</ArticleId><ArticleId IdType="pmc">PMC8770842</ArticleId><ArticleId IdType="pubmed">35000650</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Rodr&#xed;uez-Jim&#xe9;nez J., Palacios-Ce&#xf1;a M., Velasco-Arribas M., Guijarro C., de-la-Llave-Rinc&#xf3;n A.I., Fuensalida-Novo S., Elvira-Mart&#xed;nez C.M., et al. Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study. J. Infect. 2021;83:237&#x2013;279. doi: 10.1016/j.jinf.2021.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.04.036</ArticleId><ArticleId IdType="pmc">PMC8110627</ArticleId><ArticleId IdType="pubmed">33984399</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson K., Balasubramanian V., Bonilla H.F., Madrigal M., Hack I., Purington N., Singh U., Hedlin H., Jagannathan P. Clinical associations and trajectory of &#x201c;Long COVID&#x201d;. Open Forum Infect. Dis. 2021;8:S753. doi: 10.1093/ofid/ofab466.1522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab466.1522</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M., Vink-Niese F. Is it useful to question the recovery behaviour of patients with ME/CFS or Long COVID? Healthcare. 2022;10:392. doi: 10.3390/healthcare10020392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10020392</ArticleId><ArticleId IdType="pmc">PMC8872229</ArticleId><ArticleId IdType="pubmed">35207003</ArticleId></ArticleIdList></Reference><Reference><Citation>Storz M.A. Lifestyle adjustments in long-COVID management: Potential benefits of plant-based diets. Curr. Nutr. Rep. 2021;10:352&#x2013;363. doi: 10.1007/s13668-021-00369-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13668-021-00369-x</ArticleId><ArticleId IdType="pmc">PMC8429479</ArticleId><ArticleId IdType="pubmed">34506003</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zaslavsky M., Su Y., Guo J., Sikora M.J., van Unen V., Christophersen A., Chiou S.-H., Chen L., Li J., et al. KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science. 2022;376:eabi9591. doi: 10.1126/science.abi9591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abi9591</ArticleId><ArticleId IdType="pmc">PMC8995031</ArticleId><ArticleId IdType="pubmed">35258337</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Chen D., Yuan D., Lausted C., Choi J., Dai C.L., Voillet V., Duvvuri V.R., Scherler K., Troisch P., et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell. 2020;183:1479&#x2013;1495.e20. doi: 10.1016/j.cell.2020.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.037</ArticleId><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.W., Su Y., Baloni P., Chen D., Pavlovitch-Bedzyk A.J., Yuan D., Duvvuri V.R., Ng R.H., Choi J., Xie J., et al. Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nat. Biotechnol. 2022;40:110&#x2013;120. doi: 10.1038/s41587-021-01020-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01020-4</ArticleId><ArticleId IdType="pmc">PMC9206886</ArticleId><ArticleId IdType="pubmed">34489601</ArticleId></ArticleIdList></Reference><Reference><Citation>Shemesh A., Su Y., Calabrese D.R., Chen D., Arakawa-Hoyt J., Roybal K.T., Heath J.R., Greenland J.R., Lanier L.L. Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting Fc&#x3b5;RI&#x3b3; expression. J. Exp. Med. 2022;219:e20220551. doi: 10.1084/jem.20220551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20220551</ArticleId><ArticleId IdType="pmc">PMC9448639</ArticleId><ArticleId IdType="pubmed">36066491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;mer B., Knoll R., Bonaguro L., ToVinh M., Raabe J., Astaburuaga-Garc&#xed;a R., Schulte-Schrepping J., Kaiser K.M., Rieke G.J., Bischoff J., et al. Early IFN-&#x3b1; signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity. 2021;54:2650&#x2013;2669.e14. doi: 10.1016/j.immuni.2021.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.09.002</ArticleId><ArticleId IdType="pmc">PMC8416549</ArticleId><ArticleId IdType="pubmed">34592166</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>